The thermal inactivation conditions (75°C 9 35 min, 80°C 9 10 min, 85°C 9 5 min and 90°C 9 5 min) for Protamex TM following bovine whey protein concentrate (WPC) hydrolysis was studied with the view to limiting WPC hydrolysate (WPH) aggregation while maintaining bioactivity. A decrease in the amount of large WPH aggregates formed was observed at inactivation temperatures ≤85°C. However, the WPC appeared to be more hydrolysed on heating at 75°C 9 35 min, as Protamex TM was active for longer under these heating conditions. Significantly (P < 0.05), higher WPH antioxidant (oxygen radical absorbance capacity -ORAC) activity was obtained on inactivation at temperatures ≤80°C. In contrast, the dipeptidyl peptidase IV (DPP-IV) inhibitory properties of all WPH samples were similar (P > 0.05). A reduction in thermal treatment from 90°C 9 5 min to 85°C 9 5 min was sufficient to decrease the amount of large aggregates formed in the hydrolysate without altering its bioactive properties.
Introduction
Enzymatic hydrolysis of dietary proteins is commonly used in the food industry to decrease allergenicity, to increase bioactivity and digestibility and to enhance technofunctional properties (Foegeding et al., 2002; Embiriekah et al., 2017) . The enzyme employed during hydrolysis is usually inactivated to maintain hydrolysate stability during subsequent processing/storage (Whitehurst & Law, 2002) . Hydrolysis reactions are generally terminated by thermal treatment and/or pH alteration, modifications which can irreversibly inactivate enzyme activity (Eijsink et al., 2005) . Thermal treatments are preferred to avoid the addition of other chemicals to the final hydrolysate. However, heat treatment may lead to some structural rearrangements within proteins and peptides (Foegeding et al., 2002) . Therefore, the conditions (pH, substrate concentration or the temperature 9 time combination) employed during inactivation need to be carefully chosen to minimise protein and peptide aggregation, precipitation or gelation.
At laboratory scale, enzymes are commonly inactivated in a batch manner by immersion of the samples in water baths (10-20 min) at high temperature (80-90°C) (Whitehurst & Law, 2002; Nongonierma et al., 2013) . Selection of enzyme inactivation conditions (temperature 9 time) appears to be solely based on their ability to suppress enzyme activity. However, the application of different temperature 9 time combinations during heat treatment may lead to physicochemical differences between hydrolysates. Whey proteins are widely reported as a source of bioactive peptides (for reviews, see: Morris & FitzGerald, 2009; Hern andez-Ledesma et al., 2014) . However, whey proteins and whey protein-derived peptides are highly sensitive to heat treatment and may aggregate when exposed to elevated (>65°C) temperatures (Foegeding et al., 2002; Wijayanti et al., 2014) . To limit heat-induced denaturation of whey proteins and whey proteinderived peptides, the temperature applied during enzyme inactivation may be decreased while the duration of inactivation is increased (Conesa & FitzGerald, 2013) . Nevertheless, the heat treatment conditions per se may have an impact on hydrolysate bioactivity (Adjonu et al., 2013; O'Loughlin et al., 2014) .
To our knowledge, the effect of enzyme inactivation conditions on hydrolysate physicochemical and bioactive properties does not seem to have been generally studied. The aim of this study was to assess the impact of four different temperature 9 time combinations during enzyme inactivation of a whey protein hydrolysate (WPH) on its physicochemical (degree of hydrolysis (DH), molecular mass distribution, peptide profile and particle size distribution) and bioactive (dipeptidyl peptidase IV (DPP-IV) inhibition and oxygen radical absorbance capacity (ORAC)) properties. The inhibition of DPP-IV was used as an in vitro indicator of an antidiabetic effect, as its inhibition may be targeted for the improvement of serum glucose regulation in type 2 diabetes (Juillerat-Jeanneret, 2014) . As a high oxidative status may occur in type 2 diabetics (Rani & Mythili, 2014) , the ORAC value of the WPH samples was also determined.
Materials and methods

Reagents
Whey protein concentrate (WPC, 81% (w/w) protein) was obtained from Carbery Group (Ballineen, Ireland). Protamex TM was obtained from Novozymes (Bagsvaerd, Denmark). Mass spectrometry (MS) grade water and acetonitrile (MeCN), trifluoroacetic acid (TFA), trichloroacetic acid (TCA), azocasein, sodium phosphate monobasic, sodium phosphate dibasic, GlyPro-pNA, diprotin A (Ile-Pro-Ile), porcine DPP-IV (≥10 units mg À1 protein), tris(hydroxymethyl)aminomethane (TRIS), Trolox and 2,2 0 -azobis(2-methylpropionamidine)dihydrochloride (AAPH) were purchased from Sigma-Aldrich (Dublin, Ireland). Sodium hydroxide (NaOH) was obtained from VWR (Dublin, Ireland). 2,4,6-Trinitrobenzenesulfonic acid (TNBS) was obtained from Pierce Biotechnology (Medical Supply Company, Dublin, Ireland) . All other chemicals were obtained from Sigma-Aldrich and were of analytical grade unless otherwise stated.
Determination of heat inactivation conditions of Protamex
Protamex
TM was dispersed in distilled water at a concentration of 0.2% (w/w), which corresponded to the same dosage as that used during enzymatic hydrolysis of whey proteins (see Enzymatic hydrolysis of whey proteins). Immediately after enzyme suspension, this solution was immersed in a water bath set at 75, 80, 85 or 90°C. Samples were then withdrawn at 5, 10, 15, 25, 40 and 50 min. The enzyme activity in the samples was subsequently determined using the azocasein assay (Kilcawley et al., 2002) with modifications. Briefly, 500 lL of azocasein 0.5% (w/w) was mixed with 500 lL sample and incubated at 50°C for 30 min. The reaction was terminated by addition of 2 M TCA (100 lL). The absorbance was measured at 440 nm in a spectrophotometer (Cary 100 Bio UVvisible; Varian, Palo Alto, CA, USA). Subsequently, the temperature 9 time combinations required to inactivate Protamex TM in aqueous solution were applied to the whey protein hydrolysate (see Enzymatic hydrolysis of whey proteins) to verify that there was no residual proteolytic activity remaining in the hydrolysate. The residual enzyme activity was expressed relative to the activity present in a sample which was not heat inactivated (100% enzyme activity). Each experiment was carried out in triplicate (n = 3).
Enzymatic hydrolysis of whey proteins
Whey protein concentrate (10% (w/w) on a protein basis) was rehydrated in distilled water at 50°C for 1 h under gentle agitation. The solution was adjusted to pH 7.0 using NaOH (2 M). Protamex TM was added at an enzyme to substrate ratio (E:S) of 2% (w/w), and hydrolysis was carried out at 50°C for 3 h without pH regulation. The enzyme was heat inactivated using different temperature 9 time combinations, that is 75°C 9 35 min (WPH-75°C 9 35 min), 80°C 9 10 min (WPH-80°C 9 10 min), 85°C 9 5 min (WPH-85°C 9 5 min) or 90°C 9 5 min (WPH-90°C 9 5 min). Negative controls consisted of the WPC solution (10% (w/w) on a protein basis) which was not heated following 3 h incubation at 50°C (WPC-control 50°C) and WPC-control 50°C which was heat inactivated under the same conditions as the WPH samples, that is at 75°C 9 35 min (WPC-75°C 9 35 min), 80°C 9 10 min (WPC-80°C 9 10 min), 85°C 9 5 min (WPC-85°C 9 5 min) or 90°C 9 5 min (WPC-90°C 9 5 min). All hydrolysis reactions and heat inactivation conditions were performed in triplicate (n = 3). Samples were then freezedried (FreeZone 18L, Labconco, Kansas City, MO, USA) and stored at À20°C.
Determination of the DH using the TNBS method
Degree of hydrolysis was determined in triplicate (n = 3) using the TNBS method adapted to microplate format (Le Maux et al., 2016) . Leucine was used as a standard (at concentrations ranging from 0 to 4 mM) to allow determination of the primary amino group content of the samples (AN, in mg N mg À1 sample). DH was calculated using the following formula:
The amino group content of the peptide bonds (Npb) for whey proteins was 123.3 mg g À1 .
Determination of the molecular mass distribution by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and gel permeation ultra-performance liquid chromatography (GP-UPLC)
The molecular mass distribution of the samples was analysed using SDS-PAGE. Mini-PROTEAN TGX precast gels (4-20% resolving gel; Bio-Rad Laboratories Inc., Hercules, CA, USA) were run on a Mini Protean II system (Bio-Rad) according to the manufacturer's instructions. Samples were separated under nonreducing and reducing (b-mercaptoethanol) conditions. A broad range molecular weight calibration kit (6.5 to 200 kDa; Bio-Rad) was used as molecular weight marker. Gels were stained with Coomassie brilliant blue and subsequently scanned using an Odyssey imaging system (LI-COR, Lincoln, NE, USA). The intensities of the bands were analysed by densitometry using the GelAnalyser 2010a software (http://www.gelanalyzer.com/) (Lazer & Lazer, 2010) . GP-ULPC was also used for determination of molecular mass distribution as previously described (Le Maux et al., 2017) . Samples were analysed in triplicate (n = 3) on an Acquity UPLC system equipped with an Acquity BEH125 SEC column (4.6 9 150 mm, 1.7 lm) and an Acquity BEH125 SEC 1.7 lm vanguard precolumn, all from Waters (Milford, MA, USA). A mobile phase composed of MeCN/H 2 O/TFA (30.0:69.9:0.1, v/v/v) was used to elute samples (injected at a protein equivalent content of 20 lg) at a flow rate of 0.3 mL min À1 for 8 min at 30°C. The molecular mass standards ranged from 67 500 to 181 Da. Results were expressed as the proportion of the peak area obtained at 214 nm within different molecular mass ranges: <1, 1-5, 5-10 and >10 kDa.
Peptide profile analysis by reverse-phase (RP)-UPLC
Samples were analysed by RP-UPLC using a Waters Acquity UPLC system as described by Le Maux et al. (2015) with some modifications. Briefly, RP-UPLC was performed using an Acquity BEH C18 column (2.1 9 50 mm, 1.7 lm) equipped with an Acquity BEH C18 1.7 lm vanguard precolumn (Waters). Solvent A was MeCN/H 2 O/TFA (1.0:98.9:0.1, v/v/v), and solvent B was MeCN/H 2 O/TFA (90.0:9.9:0.1, v/v/v). For each sample, 56.7 lg protein equivalent was injected onto the column. A linear gradient from 100% to 40% solvent A was applied for 60 min at a flow rate of 0.2 mL min À1 . The column temperature was maintained at 40°C.
Particle size analysis by laser light scattering
The particle size distribution of the hydrolysates (WPH-75°C 9 35 min, WPH-80°C 9 10 min, WPH-85°C 9 5 min and WHP-90°C 9 5 min) and controls (WPC-control 50°C, WPC-75°C 9 35 min, WPC-80°C 9 10 min, WPC-85°C 9 5 min and WPC-90°C 9 5 min) was determined with a Malvern Mastersizer 2000 equipped with an Hydro 2000S sample dispersion system (1000 rpm stirring speed), interfaced with Mastersizer 2000 software (version 5.61; Malvern Instruments, Malvern, UK). Samples were analysed at a concentration of 8.1 mg mL À1 on a protein equivalent basis. Each sample was analysed in triplicate (n = 3), and three measurements were taken with a 10 s delay. The relative refractive and absorbance indexes were set at 1.56 and 0.001, respectively. The continuous phase (distilled water) refractive index was 1.33. The volume-weighted mean (D [4,3] ) was reported as the mean particle size.
Determination of the antioxidant capacity using the ORAC assay
The antioxidant capacity of each sample was determined using the ORAC assay as described previously . Briefly, samples were tested at a final concentration of 8.1 lg L À1 on a protein equivalent basis. Samples were resuspended in 75 mM phosphate buffer pH 7.0. Trolox was used as a positive control at final concentrations ranging from 0 to 8 lM. Samples (50 lL) and fluorescein (50 lL, final concentration 0.1 lM) were mixed in a 96-well microplate (Thermo Fisher Scientific, Waltham, MA, USA), which was incubated at 37°C for 15 min in a microplate reader (BioTek Synergy HT, Winoosky, VT, USA). The reaction was initiated by the addition of 25 lL of AAPH radical (final concentration 14.63 mM). The fluorescence was monitored over 60 min at excitation and emission wavelengths of 485 and 520 nm, respectively. The ORAC values were expressed as lmol of Trolox equivalents (TE) per g of protein equivalent. Each sample was analysed in triplicate (n = 3).
DPP-IV inhibition assay
The DPP-IV inhibitory activity of the hydrolysates was determined as described by Nongonierma & FitzGerald (2013a) . Briefly, samples were tested at final concentrations ranging from 1.0 9 10 À2 to 2.5 mg mL À1 on a protein equivalent basis. The positive control, Ile-ProIle, was assessed at final concentrations ranging from 12.5 9 10 À2 to 12.5 lg mL À1 . Samples (25 lL) were mixed with Gly-Pro-pNA (final concentration 0.200 mM) in a 96-well microplate (Sarstedt, Dublin, Ireland). DPP-IV (final concentration 0.0025 U mL À1 ) was added to the wells to initiate the reaction, and the microplate was incubated at 37°C for 60 min in a microplate reader (BioTek Synergy HT). Absorbance of the pNA released was monitored at 405 nm. The DPP-IV half maximal inhibitory concentration (IC 50 ) was determined by plotting the percentage inhibition as a function of WPH concentration expressed in mg protein equivalents mL À1 . Each sample was analysed in triplicate (n = 3).
Statistical analysis
Results are presented as the mean AE SD (n = 3). Results were compared by ANOVA with a Tukey's test at a significance level (P < 0.05). To check the absence of enzyme activity in the heat-treated WPH samples, the residual enzyme activity was analysed with a one-sample Student test (t-test, P < 0.05). All statistical analyses were performed with the R software 3.1.0 package and the Rcmdr library version 2.1-7 (R Foundation for Statistical Computing, Vienna, Austria).
Results and discussion
Residual enzyme activity of Protamex TM after heat inactivation
Preliminary experiments were performed to assess the role of heating time and temperature on inactivation of the proteolytic activity in Protamex TM . The different temperature 9 time combinations led to a decrease in enzyme activity (Fig. S1a-d) . As expected, some residual activity was still found in the samples on heating at lower temperatures and shorter times. For example, at 75°C 9 5 min the residual activity of Protamex TM was of 15.89 AE 12.95% (Fig. S1a) . However, on incubation, the proteolytic activity was not significantly different from zero (P > 0.05) at times ≥25, 10, 5 and 5 min on heating at 75, 80, 85 and 90°C, respectively.
On the basis of the above results, the heat inactivation conditions applied to the hydrolysates were 75°C 9 30 min, 75°C 9 35 min, 80°C 9 10 min, 85°C 9 5 min and 90°C 9 5 min. The residual proteolytic activity in the WPH samples after heat inactivation in the above conditions is illustrated in Fig. 1 . The residual proteolytic activity in the hydrolysates was not significantly different from zero (P > 0.05) for the WPH-75°C 9 35 min, WPH-80°C 9 10 min, WPH-85°C 9 5 min and WPH-90°C 9 5 min samples. Therefore, these conditions were selected for further studies on heat inactivation of the WPH samples.
DH of WPH samples
The DH of the WPH samples ranged from 7.1 AE 0.2% to 7.5 AE 0.8% for WPH-85°C 9 5 min and WPH-80°C 9 10 min, respectively (Table 1 ). All the DH values of the WPH samples were of the same order (P > 0.05), regardless of the heat inactivation conditions employed. An increase in DH at lower inactivation temperatures was not evidenced, possibly due to the fact that the TNBS method may not be able to detect small variations in DH.
Molecular mass distribution of WPH samples by SDS-PAGE and GP-UPLC
Bands representing the major whey proteins, that is b-lactoglobulin (b-lg), a-lactalbumin (a-la) and bovine serum albumin (BSA), were observed in the WPCcontrol 50°C, WPC-75°C 9 35 min, WPC-80°C 9 10 min, WPC-85°C 9 5 min and WPC-90°C 9 5 min on the SDS-PAGE gels (Fig. S2) . It was also evident that the WPC-75°C 9 35 min, WPC-80°C 9 10 min, WPC-85°C 9 5 min and WPC-90°C 9 5 min samples contained large aggregates that did not enter the gel under nonreducing conditions (Fig. S2a) . However, under reducing conditions, WPC-75°C 9 35 min, WPC-80°C 9 10 min, WPC-85°C 9 5 min and WPC-90°C 9 5 min displayed a similar SDS-PAGE profile to the WPC-control 50°C (Fig. S2b) . This highlighted the impact of heat processing on whey proteins aggregation and the role of disulphide linkage in same.
Large aggregates (unable to enter the gels) were also visible in the WPH profiles obtained with the nonreducing conditions (Fig. S2a) . These aggregates were dissociated under reducing conditions and able to enter the gel (Fig. S2b) . Densitometric analysis of the gels obtained under reducing conditions showed a lower proportion of b-lg (34.9%) and BSA (1.4%) in the WPH-75°C 9 35 min compared to the other three WPH samples. In addition, there was an increased proportion of low molecular mass compounds (<13 kDa) from 12.7 AE 1.5% to 39.5 AE 3.9% for WPH-90°C 9 5 min and WPH-75°C 9 35 min, respectively (Fig. 2a) .
The molecular mass distribution profile of the WPH samples, as determined by GP-UPLC (Fig. 2b) , showed that protein (>10 kDa) hydrolysis occurred within all the WPH samples. Interestingly, there was a lower proportion of proteins (>10 kDa) in the WPH samples inactivated at 75°C 9 35 min (24.4 AE 4.3%) compared to inactivation at 85°C 9 5 min (31.5 AE 1.6%, Fig. 2b ). The differences between WPH samples observed using GP-UPLC were not as obvious compared to the SDS-PAGE results, which may be due to the fact that larger aggregates may have been retained during the filtration (0.22 lm) step prior to GP-UPLC analysis.
Overall, the SDS-PAGE profiles indicate that in WPH-75°C 9 35 min, a higher extent of b-lg and BSA degradation was seen compared to that in the other samples. The greater breakdown of b-lg together with the appearance of low molecular mass compounds (<13 kDa) seen in the WPH samples heat inactivated at 75°C 9 35 min (Figs 2a,b and S2) may be explained by the fact that the proteolytic activity within Protamex TM was active for longer immediately prior to denaturation (Johnson et al., 1967; Whitehurst & Law, 2002) . Increasing enzyme inactivation temperature during WPH processing produced larger aggregates (Figs 2a,b and S2) . The larger aggregates seen in hydrolysates inactivated at temperatures ≥85°C may be linked to the higher proportion of intact proteins (i.e. b-lg and BSA) in these hydrolysates compared to WPH-75°C 9 35 min (Fig. 2a) . In addition, this may also be due to the fact that whey proteins and peptides within WPH can aggregate and gel with increasing temperature (Donovan & Mulvihill, 1987; Puyol et al., 2001; Foegeding et al., 2002; Wijayanti et al., 2014) . This may also be related to the fact that accessibility of thiol groups increases at higher temperatures, which accelerates the aggregation rate via thiol/disulphide exchange reactions (de Wit, 2009; Wijayanti et al., 2014) .
Peptide profile of WPH samples by RP-UPLC
The peptide profiles of WPC-control 50°C and WPH samples were analysed by RP-UPLC (Fig. 3) . This analysis was carried out to visualise protein breakdown following enzymatic hydrolysis and also to understand the potential role of heat inactivation on the peptides released in WPH samples. The results show a decreased peak intensity, corresponding to the major whey proteins (b-lg, a-la and BSA) eluting between 30 and 50 min, which was observed in all WPH samples compared to the WPC-control 50°C. This decrease in peak intensity of intact whey proteins is more pronounced for WPH samples heat inactivated at WPH-75°C 9 35 min and WPH-80°C 9 10 min Figure 1 Residual enzyme activity of Protamex TM measured with the azocasein assay (50°C for 30 min incubation) in the whey protein hydrolysate (WPH) samples heat inactivated at 75°C 9 30 min (WPH-75°C 9 30 min), 75°C 9 35 min (WPH-75°C 9 35 min), 80°C 9 10 min (WPH-80°C 9 10 min), 85°C 9 5 min (WPH-85°C 9 5 min) and 90°C 9 5 min (WPH-90°C 9 5 min). Values represent the mean AE SD of three replicates (n = 3). ns: residual enzyme activity not significantly different from 0 (P > 0.05), *: residual enzyme activity significantly different from 0 (P < 0.05). [Colour figure can be viewed at wileyonlinelibrary.com] Table 1 Percentage degree of hydrolysis (DH), volume-weighted mean D [4, 3] , oxygen radical absorbance capacity (ORAC) value and dipeptidyl peptidase IV (DPP-IV) half maximal inhibitory concentration (IC 50 ) of whey protein control (WPC-control 50°C) and whey protein hydrolysate (WPH) samples heat inactivated under different temperature 9 time combinations (75°C 9 35 min (WPH-75°C 9 35 min), 80°C 9 10 min (WPH-80°C 9 10 min), 85°C 9 5 min (WPH-85°C 9 5 min) or 90°C 9 5 min (WPH-90°C 9 5 min)). The DPP-IV IC 50 value of Ile-Pro-Ile, the positive control, was 3.69 AE 0.68 lM. All ORAC and DPP-IV IC 50 values are expressed in protein equivalents. Values represent the mean AE SD of three replicates (n = 3). For each assay, values with different superscript letters are significantly different (P < 0.05)
WPC-control 50˚C na 6.1 AE 0. ( Fig. 3 ). Some differences in peptide peak intensities were seen in the four WPH samples. In particular in WPH-75°C 9 35 min, five peptide peaks eluting before 35 min were more intense than in the other three samples (Fig. 3) . Peptides eluted at different retention times, which suggested that the WPH samples contained peptides having a wide range of hydrophobicity. In line with the molecular mass distribution profiles determined by SDS-PAGE (Figs 2a  and S2 ), the RP profiles also show a higher extent of b-lg breakdown in the WPH-75°C 9 35 min sample compared to the other three hydrolysates.
Particle size distribution
The WPC-control 50°C was mainly composed of small particles, having a D [4, 3] of 6.1 AE 0.4 lm ( Table 1) . The particles within the 3 h WPH sample measured immediately prior to heat inactivation had a D [4, 3] value of 2.1 AE 0.1 lm. The D [4, 3] values of WPH-75°C 9 35 min, WPH-80°C 9 10 min, WPH-85°C 9 5 min and WPH-90°C 9 5 min were not significantly different from each other (Table 1 , P > 0.05). However, differences could be observed between the particle size profiles obtained for WPH-90°C 9 5 min and the other WPH samples (Fig. S3) . A relatively lower volume was observed for the smaller particle population (~20 lm) in WPH-90°C 9 5 min sample compared to the other WPH samples. This explains the higher mean D [4, 3] value for the WPH-90°C 9 5 min samples (181.9 AE 29.1 lm) compared to the three other WPH samples (e.g. 146.2 AE 36.3 lm for WPH-80°C 9 10 min).
In the absence of heat treatment, smaller sized peptide-peptide and peptide-protein aggregates ranging between 1.4 and 7.5 kDa (Creusot et al., 2006) or having a D [4, 3] values between 49.9 and 67.0 lm (Spellman et al., 2005) have been reported within WPH Figure 2 (a) Densitometric analysis of the molecular mass distribution of the proteins/peptides in the test sample determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions and (b) protein/peptide molecular mass distribution determined by gel permeation ultra-performance liquid chromatography (GP-UPLC) of whey protein control (WPC-control 50°C) and whey protein hydrolysate (WPH) samples heat inactivated under different temperature 9 time combinations (75°C 9 35 min (WPH-75°C 9 35 min), 80°C 9 10 min (WPH-80°C 9 10 min), 85°C 9 5 min (WPH-85°C 9 5 min) or 90°C 9 5 min (WPH-90°C 9 5 min)). The molecular weight markers used for SDS-PAGE were 200.0, 116.3, 97.4, 66.2, 45.0, 31.0, 21.5, 14 .4 and 6.5 kDa. Compounds <13 kDa were labelled as 'low molecular mass compounds'. Compounds between 32 and 56 kDa were labelled as 'large molecular mass compounds'. Values represent the mean AE SD of three replicates (n = 3). For GP-UPLC, bovine serum albumin (BSA), b-lactoglobulin (b-lg), a-lactalbumin (a-la), aprotinin, bacitracin, Leu-trp-Met-Arg, Asp-Glu and Tyr were used as standards. Values represent the mean AE SD of three replicates (n = 3).
samples generated with certain enzyme preparations. In the study herein, however, no aggregation occurred prior to the heat inactivation step, showing that the formation of aggregates within WPH samples was heat-induced. Aggregation between proteins/peptides may be due to both disulphide aggregation and noncovalent interactions, which may explain the bimodal distribution of the particles within the WPH samples (Simmons et al., 2007; de Wit, 2009; Wijayanti et al., 2014) . b-Lg aggregates formed as a consequence of noncovalent interactions should be larger at heating temperatures between 75 and 85°C than those formed between 85 and 105°C (de Wit, 2009 ). The different temperature-dependent behaviour of b-lg may explain the fact that small size (<100 lm) peptide-peptide and peptide-protein aggregates can be formed within the WPH samples via noncovalent interactions when heat treated between 75 and 85°C (Spellman et al., 2005; Creusot et al., 2006) .
Antioxidant and DPP-IV inhibitory activity of WPH samples
The DPP-IV IC 50 values of all the WPH samples were lower than that of the WPC-control 50°C (Table 1) . Samples with a low IC 50 value are more potent inhibitors of DPP-IV. The higher potency of the WPH samples is linked to the release of DPP-IV inhibitory peptides during hydrolysis. The mean DPP-IV IC 50 values of the WPH samples ranged from 1.29 AE 0.21 to 1.41 AE 0.21 mg protein equivalent mL À1 for WPH-80°C 9 10 min and WPH-90°C 9 5 min, respectively. However, there was no significant difference between the DPP-IV IC 50 values for the WPH samples (P > 0.05).
The ORAC activity of the WPH samples was significantly higher than the WPC-control 50°C (P < 0.05, Table 1 ). The ORAC activity of the WPH samples ranged from 179.5 AE 25.3 to 227.6 AE 37.1 lmol TE g À1 protein equivalent for WPH-85°C 9 5 min and WPH-80°C 9 10 min, respectively. The ORAC value for WPH-75°C 9 35 min and WPH-80°C 9 10 min were significantly higher than that of WPH-85°C 9 5 min and WPH-90°C 9 5 min (P < 0.05). The higher ORAC values obtained with the WPH samples heated at 75 and 80°C may be explained by the fact that these WPH samples may have been relatively more hydrolysed (Figs 2a, 3 and S2) than WPH samples heated at 85 and 90°C. As a result of a higher extent of protein breakdown in WPH-75°C 9 35 min and WPH-80°C 9 10 min (Figs 2a, 3 and S2), it is possible that additional antioxidant peptides may have been released during heat inactivation at 75 and 80°C compared to hydrolysates inactivated at 85 and 90°C. The peptide peak differences seen, for example, in WPH-75°C 9 35 min (Fig. 3) may be linked to the higher ORAC activity of this sample. The differences in aggregation behaviour of peptides within the different hydrolysates inactivated at different temperature 9 time combination (Fig. S3 ) may also impact on the results observed. In general, highly aggregated peptides are not soluble in water and therefore, in the ORAC assay, they may not be able to scavenge the AAPH radical. This is in agreement with the observation that samples presenting a higher level of aggregation (i.e. WPH-85°C 9 5 min and WPH-90°C 9 5 min, Fig. S3 ) displayed a lower antioxidant activity.
Specific peptide sequences within food protein hydrolysates have been identified for their antioxidant and DPP-IV inhibitory activities (Power et al., 2013; Lacroix & Li-Chan, 2016) . These peptides can differ in length and general physicochemical properties. The ORAC activity and DPP-IV IC 50 values observed herein were of the same order as those reported for other WPH samples in the literature. For instance, the DPP-IV inhibitory potency of whey proteins hydrolysed for 4 h with a food-grade gastrointestinal preparation (Nongonierma & FitzGerald, 2013a) or Corolase PP (Nongonierma & FitzGerald, 2013b ) was 1.43 AE 0.27 and 1.33 AE 0.17 mg mL À1 , respectively. An ORAC value of 336.8 AE 24.3 lmol TE g À1 protein Figure 3 Representative reverse-phase ultra-performance liquid chromatography (RP-UPLC) profiles obtained at 214 nm for (1) whey protein control (WPC-control 50°C) and whey protein hydrolysate (WPH) heat inactivated at (2) 75°C 9 35 min (WPH-75°C 9 35 min), (3) 80°C 9 10 min (WPH-80°C 9 10 min), (4) 85°C 9 5 min (WPH-85°C 9 5 min) and (5) 90°C 9 5 min (WPH-90°C 9 5 min). The arrows indicate peptide peaks were major differences are seen between WPH-75°C 9 35 min and the three other WPH samples.
equivalent was described for WPC hydrolysed with pepsin for 2 h (Conway et al., 2013) . A tryptic digest of b-lg obtained after 24 h hydrolysis had an ORAC value 467.7 AE 25.0 lmol TE. g À1 dry weight (Power et al., 2014) .
Conclusions
This study demonstrates the importance of carefully selecting WPH enzyme thermal inactivation conditions. Under the conditions used herein, a reduction in inactivation temperature from 90 to 85°C was sufficient to decrease the proportion of large aggregates in the WPH samples. However, decreasing the temperature to 75°C, which was associated with a longer enzyme inactivation time, did not allow further reduction in the amount of large aggregates formed. The peptide composition of the WPH samples may be linked to their bioactive properties. Differences were seen in the peptide profiles of WPH samples as a function of the heat treatment applied. These did not alter DPP-IV inhibitory properties of the WPH samples, while they had an effect on their ORAC activities. This study has demonstrated that the enzyme activity per se should not be the only parameter considered when selecting heat inactivation temperature 9 time conditions for WPH samples. It is not recommended to decrease the heat inactivation temperature of Protamex TM WPH samples below 85°C as the longer time required for enzyme inactivation may modify sample physicochemical properties (aggregation, peptide profile), which in turn may impact on its bioactivity (e.g. ORAC and DPP-IV inhibitory activities). Future work may include study of the impact of temperature 9 time combinations employed during heat inactivation of WPH at an industrially relevant scale and in continuous hydrolysate production processes.
